The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non–Small Cell Lung Cancer Growth
Article in Molecular Cancer Therapeutics (June 2013)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
Article in Molecular Cancer Therapeutics (September 2012)
Identification of Common Predictive Markers of In vitro Response to the Mek Inhibitor Selumetinib (AZD6244; ARRY-142886) in Human Breast Cancer and Non–Small Cell Lung Cancer Cell Lines
Article in Molecular Cancer Therapeutics (July 2010)